Bioequivalence of Two NovoLog® Formulations in Subjects With Type 1 Diabetes

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01464099
Recruitment Status : Completed
First Posted : November 3, 2011
Last Update Posted : October 28, 2016
Information provided by (Responsible Party):
Novo Nordisk A/S

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : November 2008
  Study Completion Date : November 2008